Wednesday, October 21, 2026

4:30 PM - 5:15 PM

Investment & Global Growth Breakout Room

---

Details

Capital Sprint: Public Markets showcases listed life sciences companies with a clear and current investment proposition, substantive progress or validation, and significant value-inflection points ahead. In a series of rapid three-minute, no-slide pitches, selected companies will distil their investment thesis, where the company is today, the evidence and progress underpinning its position, the catalysts ahead, and the pathway to shareholder value creation. Designed for public-market investors and other capital-market participants, Capital Sprint: Public Markets provides a fast-paced view of biotechnology, medtech and health innovation companies with established public-market relevance and a compelling forward investment case. Each pitch is followed by immediate questions and observations from an investor panel. The format is intentionally direct: no slides, no extended corporate presentations, just a concise articulation of the investment proposition, upcoming catalysts and what investors should understand about the company now.

---

Speaker